Chemokines and neurodegeneration in the early stage of experimental ischemic stroke

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Wolinski, Pawel ^a   Glabinski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CCL2 PROTEIN, MOUSE; CCL3 PROTEIN, MOUSE; CCL5 PROTEIN, MOUSE; CXCL2 CHEMOKINE; CXCL2 PROTEIN, MOUSE; ENDOTHELIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; LYMPHOCYTE MIGRATION; MACROPHAGE MIGRATION; MOUSE; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BRAIN; CEREBROVASCULAR ACCIDENT; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DEGENERATIVE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOKINE CCL5; CHEMOKINE CXCL2; CHEMOKINES; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFLAMMATION; LYMPHOCYTES; MACROPHAGES; MICE; NEURODEGENERATIVE DISEASES; REAL-TIME POLYMERASE CHAIN REACTION; STROKE;

EID: 84890099181     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/727189     Document Type: Article

References (40)

1. Dirnagl U., Iadecola C., Moskowitz M. A., Pathobiology of ischaemic stroke: an integrated view. Trends in Neurosciences 1999 22 9 391 397 2-s2.0-0033199996 10.1016/S0166-2236(99)01401-0 (Pubitemid 29453643)
2. Hossmann K.-A., Pathophysiology and therapy of experimental stroke. Cellular and Molecular Neurobiology 2006 26 7-8 1057 1083 2-s2.0-33845547792 10.1007/s10571-006-9008-1 (Pubitemid 44924031)
3. 2+-permeable AMPA receptor promotes delayed cell death of hippocampal CA1 neurons following transient forebrain ischemia. Neuroscience Research 2003 46 1 41 51 2-s2.0-0037493781 10.1016/S0168-0102(03)00023-3 (Pubitemid 36506608)
4. 2+-permeable AMPA receptor channels primes cell death in transient forebrain ischemia. Neuron 2004 43 1 43 55 2-s2.0-3242700615 10.1016/j.neuron.2004.06.017 (Pubitemid 38952818)
5. Yeh T.-H., Hwang H.-M., Chen J.-J., Wu T., Li A. H., Wang H.-L., Glutamate transporter function of rat hippocampal astrocytes is impaired following the global ischemia. Neurobiology of Disease 2005 18 3 476 483 2-s2.0-14744297686 10.1016/j.nbd.2004.12.011 (Pubitemid 40332707)
6. Ludewig P., Sedlacik J., Gelderblom M., Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke. Circulation Research 2013 113 8 1013 1022
7. Abdullah A., Ssefer V., Ertugrul U., Evaluation of serum oxidant/antioxidant balance in patients with acute stroke. Journal of Pakistan Medical Association 2013 63 5 590 593
8. Hyun H., Lee K., Min K. H., Ischemic brain imaging using fluorescent gold nanoprobes sensitive to reactive oxygen species. Journal of Controlled Release 2013 170 3 352 357
9. Losy J., Zaremba J., Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke. Stroke 2001 32 11 2695 2696 2-s2.0-0035168891 (Pubitemid 33055326)
10. Stowe A. M., Wacker B. K., Cravens P. D., Perfater J. L., Li M. K., Hu R., Freie A. B., Stüve O., Gidday J. M., CCL2 upregulation triggers hypoxic preconditioning-induced protection from stroke. Journal of Neuroinflammation 2012 9, article 33 2-s2.0-84856888721 10.1186/1742-2094-9-33
11. Arakelyan A., Petrkova J., Hermanova Z., Boyajyan A., Lukl J., Petrek M., Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. Mediators of Inflammation 2005 2005 3 175 179 2-s2.0-25644437697 10.1155/MI.2005.175 (Pubitemid 41381527)
12. Sieber M. W., Claus R. A., Witte O. W., Frahm C., Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke. PLoS ONE 2013 8 1 e52982
13. Zaremba J., Ilkowski J., Losy J., Serial measurements of levels of the chemokines CCL2, CCL3 and CCL5 in serum of patients with acute ischaemic stroke. Folia Neuropathologica 2006 44 4 282 289 2-s2.0-33846135757 (Pubitemid 46075787)
14. Montecucco F., Lenglet S., Gayet-Ageron A., Bertolotto M., Pelli G., Palombo D., Pane B., Spinella G., Steffens S., Raffaghello L., Pistoia V., Ottonello L., Pende A., Dallegri F., MacH F., Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. Stroke 2010 41 7 1394 1404 2-s2.0-77954176108 10.1161/STROKEAHA.110.578369
15. Canouï-Poitrine F., Luc G., Mallat Z., Machez E., Bingham A., Ferrieres J., Ruidavets J.-B., Montaye M., Yarnell J., Haas B., Arveiler D., Morange P., Kee F., Evans A., Amouyel P., Ducimetiere P., Empana J.-P., Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology 2011 77 12 1165 1173 2-s2.0-80555125083 10.1212/WNL. 0b013e31822dc7c8
16. Tokami H., Ago T., Sugimori H., RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke. Brain Research 2013 1517 122 132
17. Wang X., Li X., Yaish-Ohad S., Sarau H. M., Barone F. C., Feuerstein G. Z., Molecular cloning and expression of the rat monocyte chemotactic protein-3 gene: a possible role in stroke. Molecular Brain Research 1999 71 2 304 312 2-s2.0-0032740918 10.1016/S0169-328X(99)00203-X (Pubitemid 29492974)
18. Wang X., Li X., Schmidt D. B., Foley J. J., Barone F. C., Ames R. S., Sarau H. M., Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke. Molecular Pharmacology 2000 57 6 1190 1198 2-s2.0-0034125046 (Pubitemid 30354391)
19. Terao Y., Ohta H., Oda A., Nakagaito Y., Kiyota Y., Shintani Y., Macrophage inflammatory protein-3alpha plays a key role in the inflammatory cascade in rat focal cerebral ischemia. Neuroscience Research 2009 64 1 75 82 2-s2.0-64249155625 10.1016/j.neures.2009.01.017
20. Schönemeier B., Schulz S., Hoellt V., Stumm R., Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain. Journal of Neuroimmunology 2008 198 1-2 39 45 2-s2.0-47249141913 10.1016/j.jneuroim.2008.04.010
21. Sibson N. R., Blamire A. M., Perry V. H., Gauldie J., Styles P., Anthony D. C., TNF- α reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway. Brain 2002 125 11 2446 2459 2-s2.0-0036844884 (Pubitemid 35303504)
22. Hughes P. M., Anthony D. C., Ruddin M., Botham M. S., Rankine E. L., Sablone M., Baumann D., Mir A. K., Perry V. H., Focal lesions in the rat central nervous system induced by endothelin-1. Journal of Neuropathology and Experimental Neurology 2003 62 12 1276 1286 2-s2.0-0344305375 (Pubitemid 37494196)
23. Northington F. J., Ferriero D. M., Graham E. M., Traystman R. J., Martin L. J., Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis. Neurobiology of Disease 2001 8 2 207 219 2-s2.0-0035028936 10.1006/nbdi.2000.0371 (Pubitemid 32382476)
24. Chan K. C., Cai K. X., Su H. X., Early detection of neurodegeneration in brain ischemia by manganese-enhanced MRI. 2008 Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2008 3884 3887
25. Rodriguez-Grande B., Blackabey V., Gittens B., Loss of substance P and inflammation precede delayed neurodegeneration in the substantia nigra after cerebral ischemia. Brain, Behavior, and Immunity 2013 29 51 61
26. Kochanek P. M., Hallenbeck J. M., Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992 23 9 1367 1379 2-s2.0-0026667919
27. Barone F. C., Arvin B., White R. F., Miller A., Webb C. L., Willette R. N., Lysko P. G., Feuerstein G. Z., Tumor necrosis factor- α: a mediator of focal ischemic brain injury. Stroke 1997 28 6 1233 1244 2-s2.0-0030976856 (Pubitemid 27248902)
28. Feuerstein G. Z., Wang X., Barone F. C., The role of cytokines in the neuropathology of stroke and neurotrauma. NeuroImmunoModulation 1998 5 3-4 143 159 2-s2.0-0031666486 10.1159/000026331 (Pubitemid 28417026)
29. Chiba T., Itoh T., Tabuchi M., Interleukin-1beta accelerates the onset of stroke in stroke-prone spontaneously hypertensive rats. Mediators of Inflammation 2013 2012 701976
30. Chen Y., Hallenbeck J. M., Ruetzler C., Bol D., Thomas K., Berman N. E. J., Vogel S. N., Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. Journal of Cerebral Blood Flow and Metabolism 2003 23 6 748 755 2-s2.0-0038796526 (Pubitemid 36713680)
31. Minami M., Satoh M., Chemokines and their receptors in the brain: pathophysiological roles in ischemic brain injury. Life Sciences 2003 74 2-3 321 327 2-s2.0-0242289611 10.1016/j.lfs.2003.09.019 (Pubitemid 37357063)
32. Gourmala N. G., Limonta S., Bochelen D., Sauter A., Boddeke H. W. G. M., Localization of macrophage inflammatory protein: macrophage inflammatory protein-1 expression in rat brain after peripheral administration of lipopolysaccharide and focal cerebral ischemia. Neuroscience 1999 88 4 1255 1266 2-s2.0-0032890085 10.1016/S0306-4522(98)00295-4 (Pubitemid 28547002)
33. Takami S., Minami M., Nagata I., Namura S., Satoh M., Chemokine receptor antagonist peptide, viral MIP-II, protects the brain against focal cerebral ischemia in mice. Journal of Cerebral Blood Flow and Metabolism 2001 21 12 1430 1435 2-s2.0-0035205906 (Pubitemid 33117183)
34. Terao S., Yilmaz G., Stokes K. Y., Russell J., Ishikawa M., Kawase T., Granger D. N., Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemiareperfusion. Stroke 2008 39 9 2560 2570 2-s2.0-52449112645 10.1161/STROKEAHA.107.513150
35. Rabuffetti M., Sciorati C., Tarozzo G., Clementi E., Manfredi A. A., Beltramo M., Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp- chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines. Journal of Neuroscience 2000 20 12 4398 4404 2-s2.0-0034660250 (Pubitemid 30396604)
36. Offner H., Subramanian S., Parker S. M., Afentoulis M. E., Vandenbark A. A., Hurn P. D., Experimental stroke induces massive, rapid activation of the peripheral immune system. Journal of Cerebral Blood Flow and Metabolism 2006 26 5 654 665 2-s2.0-33646382597 10.1038/sj.jcbfm.9600217
37. Vikman P., Ansar S., Henriksson M., Stenman E., Edvinsson L., Cerebral ischemia induces transcription of inflammatory and extracellular-matrix-related genes in rat cerebral arteries. Experimental Brain Research 2007 183 4 499 510 2-s2.0-35648950527 10.1007/s00221-007-1062-5 (Pubitemid 350029365)
38. Hurn P. D., Subramanian S., Parker S. M., Afentoulis M. E., Kaler L. J., Vandenbark A. A., Offner H., T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. Journal of Cerebral Blood Flow and Metabolism 2007 27 11 1798 1805 2-s2.0-35448947910 10.1038/sj.jcbfm.9600482 (Pubitemid 47624547)
39. Brait V. H., Rivera J., Broughton B. R. S., Lee S., Drummond G. R., Sobey C. G., Chemokine-related gene expression in the brain following ischemic stroke: no role for CXCR2 in outcome. Brain Research 2011 1372 169 179 2-s2.0-79151470215 10.1016/j.brainres.2010.11.087
40. Copin J. C., da Silva R. F., Fraga-Silva R. A., Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice. Journal of Cerebral Blood Flow & Metabolism 2013 33 4 490 498